Metraipolis › archive › dc_a39bf524c0dc

Efficacy and Safety of Biologic and Targeted Synthetic DMARDs in Young-Onset Rheumatoid Arthritis: A Systematic Review — Europe PMC PMID:41752863

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41752863
DOI
10.3390/life16020225
License (as archived)
solo-consultazione
Archived
2026-11-06T11:09:39.319Z
SHA-256 of the archived text
eec0428161add855c5800a6a0d3c092f86b2834368b33d6619e48e90695ebe89
Stable URL of this page
https://metraipolis.com/documento/dc_a39bf524c0dc

How to cite

Efficacy and Safety of Biologic and Targeted Synthetic DMARDs in Young-Onset Rheumatoid Arthritis: A Systematic Review — Europe PMC PMID:41752863 — Europe PMC (en), https://europepmc.org/article/MED/41752863 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a39bf524c0dc (Metraipolis archive dc_a39bf524c0dc, sha256 eec0428161add855c5800a6a0d3c092f86b2834368b33d6619e48e90695ebe89)
BibTeX
@misc{dca39bf524c0dc,
  title = {Efficacy and Safety of Biologic and Targeted Synthetic DMARDs in Young-Onset Rheumatoid Arthritis: A Systematic Review — Europe PMC PMID:41752863},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41752863},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a39bf524c0dc; sha256 eec0428161add855c5800a6a0d3c092f86b2834368b33d6619e48e90695ebe89},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41752863. Agents can read the archived copy with the MCP tool read_document.